Membrane Transporters/Ion Channels
-
AMPA receptor modulator
Farampator是一种AMPA受体正调节剂,它可以改善短期记忆,但会损害情景记忆。
了解更多
-
AMPA desensitization 抑制剂
Cyclothiazide是苯并噻二叠氮,可作为AMPA受体的增效剂,正向调节其对谷氨酸的响应(EC50 = 3.8 M)。
了解更多
-
AMPA/kainate 拮抗剂
CNQX是一种竞争性的非NMDA谷氨酸受体拮抗剂(AMPA和海藻酸酯受体的IC50分别为0.3和1.5 uM,而NMDA受体的IC50 = 25 uM)。
了解更多
-
AMPA/kainate 拮抗剂
CNQX disodium salt,AMPA/海藻酸酯拮抗剂CNQX(GLXC-11053)的水溶性形式。
了解更多
-
AMPA 拮抗剂
GYKI53655 Hydrochloride是一种非竞争性AMPA和海藻酸酯受体拮抗剂。
了解更多
-
positive AMPAR modulator
CX546 is a selective positive AMPAR modulator; the prototypical ampakine agent.
了解更多
-
non-competitive AMPAR antagonist
CFM-2 is a selective non-competitive AMPAR antagonist.
了解更多
-
AMPA/kainate receptors agonist
(S)-Willardiine is a potent agonist of AMPA/kainate receptors with EC50 of 44.8 uM.
了解更多
-
AMPA antagonist
Becampanel (AMP397) is the first competitive AMPA antagonist and an antiepileptic agent.
了解更多
-
AMPA 拮抗剂
Tezampanel是AMPA和离子型谷氨酸受体的海藻酸盐家族的拮抗剂,对海藻酸盐受体的GluR5亚型具有选择性。
了解更多
-
AMPA 拮抗剂
YM90K hydrochloride是一种选择性AMPA受体拮抗剂,在局部缺血后给药后,可延迟整体缺血模型中的神经元死亡和局部缺血模型中的脑梗塞。
了解更多
-
AMPA/kainate receptor 拮抗剂
Talampanel是AMPA受体的非竞争性拮抗剂,具有抗癫痫活性。
了解更多
-
AMPA 拮抗剂
CP 465022 hydrochloride是一种选择性的非竞争性AMPA拮抗剂,在大鼠皮质神经元中的IC50为25 nM,显示出有效的抗惊厥活性。
了解更多
-
AMPAR negative modulator
JNJ-61432059 is an oral active and selective negative modulator of AMPAR associated with trans-membrane AMPAR regulatory protein (TARP) γ-8, with a pIC50 of 9.7 for GluA1/γ-8.
了解更多
-
AMPA receptor antagonist
SYM 2206 is a novel, potent, non-competitive AMPA receptor antagonist.
了解更多
-
AMPA receptor positive allosteric modulator
PF-4778574 is a potent AMPA receptor positive allosteric modulator (PAM) that has been shown to enhance cognition in animal models.
了解更多
-
AMPA/kainate antagonist
Fanapanel (ZK200775) is a highly selective AMPA/kainate antagonist with little activity against NMDA; have Ki values of 3.2 nM, 100 nM, and 8.5 μM against quisqualate, kainate, and NMDA, respectively.
了解更多
-
AMPAR agonist
(S)-(-)-5-Fluorowillardiine is a potent and specific AMPAR agonist.
了解更多
-
CP-AMPA receptors antagonist
Naspm trihydrochloride (1-Naphthylacetyl spermine trihydrochloride), a synthetic analogue of Joro spider toxin, is a calcium permeable AMPA (CP-AMPA) receptors antagonist.
了解更多
-
AMPA/kainate antagonist
Fanapanel hydrate (ZK200775 hydrate) is a highly selective AMPA/kainate antagonist with little activity against NMDA; have Ki values of 3.2 nM, 100 nM, and 8.5 μM against quisqualate, kainate, and NMDA, respectively.
了解更多
-
AMPA receptors potentiator
Mibampator (LY451395) is a potent and highly selective potentiator of the AMPA receptors.
了解更多
-
AMPAR antagonist
Philanthotoxin 74 dihydrochloride (PhTx 74) is an AMPAR antagonist; inhibits GluR3 and GluR1 with IC50s of 263 and 296 nM, respectively.
了解更多
-
AMPA receptors allosteric modulator
PEPA is an allosteric modulator of AMPA receptors; binds to the GluA2o and GluA3o LBDs and can be utilized as an indicator of AMPA receptor heterogeneity.
了解更多
-
AMPA receptors positive allosteric modulator
CMPDA is a positive allosteric modulator of AMPA receptors with EC50s of 45.4 ?? 4.2 nM/63.4 ?? 5.6 nM for GluA2i/GluA2o receptor.
了解更多
-
AMPA (CP-AMPA) receptors antagonist
Naspm (1-Naphthyl acetyl spermine), a synthetic analogue of Joro spider toxin, is a calcium permeable AMPA (CP-AMPA) receptors antagonist.
了解更多
-
MCT1 and MCT2 抑制剂
AR-C155858是单羧酸转运蛋白mct1和mct2的有效抑制剂,它们与涉及跨膜螺旋7-10的细胞内位点结合。
了解更多
- Charlotte Petersen, .et al. MCT1 and MCT4 Expression and Lactate Flux Activity Increase During White and Brown Adipogenesis and Impact Adipocyte Metabolism, Sci Rep, 2017, 7: 13101 PMID: 29026134
- Kong SC, .et al. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells, Pancreas, 2016, Aug;45(7):1036-47 PMID: 26765963
- Anne Poder, .et al. Roles of acid-extruding ion transporters in regulation of breast cancer cell growth in a 3-dimensional microenvironment, Mol Cancer, 2016, 15: 45 PMID: 27266704
- Eumorphia G. Konstantakou, .et al. 3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants, Mol Cancer, 2015, 14: 135 PMID: 26198749
- Álvarez Z, .et al. Neurogenesis and vascularization of the damaged brain using a lactate-releasing biomimetic scaffold., Biomaterials., 2014, 35(17):4769-81 PMID: 24636215
- Álvarez Z, .et al. Neuronal Progenitor Maintenance Requires Lactate Metabolism and PEPCK-M-Directed Cataplerosis., Cereb Cortex., 2014, 26(3):1046-58 PMID: 25452568
-
MCT 抑制剂
CHC是单羧酸转运(MCT)抑制剂。在神经胶质瘤中具有抗肿瘤和抗血管生成活性;降低U251细胞的糖酵解代谢,迁移和侵袭。
了解更多
-
MCT1 抑制剂
AZD-3965(AZD3965)是具有1.6 nM结合亲和力的单羧酸盐转运蛋白1(MCT1)的选择性抑制剂,是MCT2的6倍选择性,在10μM时不抑制MCT4。
了解更多
- Lu Gao, .et al. Trophoblast-derived Lactic Acid Orchestrates Decidual Macrophage Differentiation via SRC/LDHA Signaling in Early Pregnancy, Int J Biol Sci, 2022, Jan 1;18(2):599-616 PMID: 35002512
-
MCT1 抑制剂
AR-C117977是一种有效的MCT1抑制剂,可以降低体内和体外的免疫应答,维持长期移植物存活,并诱导操作耐受性。
了解更多
-
MCT 抑制剂
7ACC2是一种新型有效的MCT抑制剂,IC50为11 nM,可抑制[14C]-乳酸盐涌入。针对癌细胞中乳酸转运的新型抗肿瘤治疗。
了解更多
-
MCT 抑制剂?
7ACC1在富含乳酸的肿瘤微环境中选择性干扰乳酸通量;在表达MCT1和MCT4转运蛋白的肿瘤细胞中,乳酸抑制乳酸盐流入,但不流出。
了解更多
- Daniel Gundel, .et al. Preclinical Evaluation of [18F]FACH in Healthy Mice and Piglets: An 18F-Labeled Ligand for Imaging of Monocarboxylate Transporters with PET, Int J Mol Sci, 2021, Feb; 22(4): 1645 PMID: 33562048
-
MCT 抑制剂
UK 5099是质膜单羧酸盐转运蛋白(MCT)和线粒体丙酮酸载体(MPC)的有效抑制剂。抑制丙酮酸依赖性的氧气消耗,IC50为50 nM。
了解更多
-
MCT1 inhibitor
BAY-8002 is a potent, selective, orally active inhibitor of monocarboxylate transporter 1 (MCT1), with an IC50 of 85 nM in the MCT1-expressing DLD-1 cells, displays excellent selectivity against MCT4. Anti-tumor activity.
了解更多
-
SGLT2 抑制剂
Dapagliflozin (BMS512148)抑制钠-葡萄糖转运蛋白(SGLT2)的亚型2,后者负责肾脏中至少90%的葡萄糖重吸收。
了解更多
- David Papadopoli, .et al. Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozin, Neoplasia, 2021, Apr;23(4):391-399 PMID: 33784591
- Neil Tanday, .et al. Dapagliflozin exerts positive effects on beta cells, decreases glucagon and does not alter beta- to alpha-cell transdifferentiation in mouse models of diabetes and insulin resistance, Biochem Pharmacol, 2020, Jul;177:114009 PMID: 32360307
- Subramaniam M, .et al. Comparison of Intestinal Glucose Flux and Electrogenic Current Demonstrates Two Absorptive Pathways in Pig and One in Nile Tilapia and Rainbow Trout, Am J Physiol Regul Integr Comp Physiol, 2019, Nov 20 PMID: 31746628
- Marina Subramaniam, .et al. Sigmoidal kinetics define porcine intestinal segregation of electrogenic monosaccharide transport systems as having multiple transporter population involvement, Physiol Rep, 2019, May; 7(9): e14090 PMID: 31062524
- Angelopoulou A, .et al. Magnetic Nanoparticles for the Delivery of Dapagliflozin to Hypoxic Tumors: Physicochemical Characterization and Cell Studies, AAPS PharmSciTech, 2018, Feb;19(2):621-633 PMID: 8924948
-
SGLT2 抑制剂
canagliflozin是2型亚钠葡萄糖转运蛋白(SGLT2)的抑制剂,作用于hSGLT2,无细胞试验中IC50为2.2 nM,比作用于hSGLT1选择性高413倍。
了解更多
- David Papadopoli, .et al. Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozin, Neoplasia, 2021, Apr;23(4):391-399 PMID: 33784591
- Angelopoulou A, .et al. Canagliflozin-loaded magnetic nanoparticles as potential treatment of hypoxic tumors in combination with radiotherapy, Nanomedicine, 2018, Oct;13(19):2435-2454 PMID: 30311542
-
SGLT2 抑制剂
EGT1442是有效的选择性SGLT2抑制剂。
了解更多
-
Empagliflozin是一种有效的选择性葡萄糖钠共转运蛋白-2抑制剂,目前正在开发中,用于治疗2型糖尿病。
了解更多
- Yu-Jung Heo, .et al. Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway, Biomedicines, 2022, Apr 29;10(5):1032 PMID: 35625768
- Nami Lee, .et al. Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF- κB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways, J Immunol Res, 2021, Jun 2;2021:9944880 PMID: 34124273
- CN Koyani, .et al. Empagliflozin Protects Heart From Inflammation and Energy Depletion via AMPK Activation, Pharmacol Res, 2020, May 17;158:104870 PMID: 32434052
-
SGLT 抑制剂?
LX4211是双重SGLT1/SGLT2抑制剂。
了解更多
-
SGLT2 抑制剂
Tofogliflozin是亚型2钠葡萄糖转运蛋白(SGLT2)的抑制剂,可引起肾脏中至少90%的葡萄糖重吸收。
了解更多
-
SGLT2 抑制剂
Remogliflozin抑制钠葡萄糖转运蛋白(SGLT2),后者负责肾脏中的葡萄糖重吸收。
了解更多
-
SGLT2 抑制剂
Ipragliflozin是一种高效的选择性SGLT2抑制剂,IC50为2.8 nM。SGLT1/3/4/5/6的效力很小且没有效力。
了解更多
-
SGLT2 抑制剂
Luseogliflozin是由Taisho Pharmaceutical开发的一种口服活性第二代钠葡萄糖共转运蛋白2(SGLT2)抑制剂,用于治疗2型糖尿病(T2DM)患者。
了解更多
-
Na+-glucose transporter 抑制剂
T-1095是Na+-葡萄糖共转运蛋白(SGLTs)的有效和选择性抑制剂。
了解更多
-
SGLT2 抑制剂
Canagliflozin hemihydrate是半水形式的卡格列嗪,是一种SGLT2抑制剂,在无细胞检测中hSGLT2的IC50为2.2 nM,其选择性比hSGLT1高413倍。
了解更多
-
SGLT inhibitor
Ertugliflozin pidolate belongs to the class of potent and selective inhibitors of the sodium-dependent glucose cotransporters (SGLT), more specifically the type 2 which is responsible for about 90% of the glucose reabsorption from glomerulus.
了解更多
-
SGLT1 抑制剂
SGL5213 is a potent, oral active and low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor, with IC50 values of 29 nM and 20 nM for hSGLT1 and hSGLT2, respectively.
了解更多
-
SGLT2 抑制剂
Dapagliflozin impurity is an enantiomer of Dapagliflozin which is a sodium-glucose transporter 2 inhibitor.
了解更多
-
SGLT1/SGLT2 抑制剂
Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor.
了解更多
-
Ivermectin是一种广谱抗寄生虫阿维菌素药物。
了解更多
-
CaCC blocker
Talniflumate是一种钙激活的氯离子通道(CaCC)(hCLCA1/mCLCA3)阻滞剂;在细胞培养和动物模型中减少粘蛋白的合成和释放。
了解更多